FORM DEF 14A

Company

IGC Pharma, Inc.

Filed

December 13, 2019

Period of Report

January 7, 2020

Accession Number

0001185185-19-001718

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →